Wanbury Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
WANBURY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250 and 4.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Wanbury Limited has submitted its financial results to the stock exchange for the quarter and half-year ended September 30, 2025. This is a routine quarterly compliance filing under SEBI listing requirements. Investors should review the detailed results document for specifics on revenue, profitability, and segment performance. The actual numbers, comparisons, and any management commentary would be available in the accompanying financial result PDF.
No immediate price-impacting news from this headline alone; the actual results figures and any management commentary in the detailed filing will determine the stock's reaction.